4Filing Date: Jan 5, 2026

Guardant Health (GH) 4: Eltoukhy Helmy bought 4,815 shares of Common Stock at $N/A… (Jan 5, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001752968-26-000002
Total Value$1.35M
Trades6
Insiders1

Transaction Details

Eltoukhy Helmy
Co-Chief Executive Officer, Director·Direct
Tax W/H · Dispose
Common Stock
Shares-10.79K
Price$102.14
Total Value$1.10M
Shares Owned After2.06M
Transaction DateJan 1, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Eltoukhy Helmy
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-24.00K
Price$0.00
Total Value$0
Shares Owned After95.99K
Transaction DateJan 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Eltoukhy Helmy
Co-Chief Executive Officer, Director·Direct
Exercise · Acquire
Common Stock
Shares+24.00K
Price$0.00
Total Value$0
Shares Owned After2.07M
Transaction DateJan 1, 2026
Eltoukhy Helmy
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-4.82K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateDec 31, 2025
Footnotes ▸

This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. | Not applicable for Restricted Stock Units.

Eltoukhy Helmy
Co-Chief Executive Officer, Director·Direct
Tax W/H · Dispose
Common Stock
Shares-2.44K
Price$102.14
Total Value$249.3K
Shares Owned After2.05M
Transaction DateDec 31, 2025
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Eltoukhy Helmy
Co-Chief Executive Officer, Director·Direct
Exercise · Acquire
Common Stock
Shares+4.82K
Price$0.00
Total Value$0
Shares Owned After2.05M
Transaction DateDec 31, 2025

Post-Transaction Holdings

Eltoukhy Helmy · Co-Chief Executive Officer, Director
SecuritySharesChange
Common Stock2.06M+15.58K (0.76%)
Restricted Stock Units95.99K-28.81K (-23.09%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2025-12-31 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Eltoukhy Helmy CIK: 0001752968 Role: Director, Officer (Co-Chief Executive Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2025-12-31 | Code: M (Exercise of derivative) Shares: +4,815 | Price: $0.00 Shares Owned After: 2,051,958 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2025-12-31 | Code: F (Payment of exercise/tax) Shares: -2,441 | Price: $102.14 Total Value: $249,323.74 Shares Owned After: 2,049,517 | Ownership: D (Direct) Footnotes: [F1] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. [Transaction #3] Security: Common Stock Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: +23,997 | Price: $0.00 Shares Owned After: 2,073,514 | Ownership: D (Direct) [Transaction #4] Security: Common Stock Date: 2026-01-01 | Code: F (Payment of exercise/tax) Shares: -10,788 | Price: $102.14 Total Value: $1,101,886.32 Shares Owned After: 2,062,726 | Ownership: D (Direct) Footnotes: [F1] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2025-12-31 | Code: M (Exercise of derivative) Shares: -4,815 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F2] This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. [F3] Not applicable for Restricted Stock Units. [Transaction #2] Security: Restricted Stock Units Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: -23,997 | Price: $0.00 Shares Owned After: 95,989 | Ownership: D (Direct) Footnotes: [F4] This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. --- Footnotes (Complete Index) --- F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. F2: This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. F3: Not applicable for Restricted Stock Units. F4: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy (2026-01-05)

keid analysis is for reference only and does not constitute investment advice.